companies innovating obesity treatment glp-1 drugs 2025 Agonists Weight Loss Market Report, 2025-2030 GLP-1s and Obesity Coverage: Differing
Description
95% CI 0.791.39) or 4-point MACE (HR 0.95
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
Are people going blind from GLP-1 medications
In India, GLP-1 drugs can only be prescribed by endocrinologists, internal medicine specialists, and cardiologists
Additionally, it has shown improvements in blood pressure, lipid profiles, and blood sugar
